{
  "id": 19778841,
  "title": "Immunovant director Atul Pande sells $108,000 in stock",
  "url": "https://urgent.news/2026/11/13/immunovant-director-atul-pande-sells-108-000-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-13T08:16:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/immunovant-director-atul-pande-sells-108000-in-stock-93CH-5024398"
  },
  "original_language": "en",
  "account": "Immunovant director Atul Pande sold 3,000 shares of the company's common stock for a total of $108,000 on November 11, 2026. At the time of the sale, each share was priced at $36.00. The current trading price for Immunovant's stock is $35.05, which represents a 54% return over the past year. However, InvestingPro analysis indicates that the shares may be overvalued at their current price. Prior to this sale, Mr. Pande exercised options to acquire an additional 3,000 shares, which were obtained at an exercise price of $8.43 per share, totaling $25,290. Both the option exercise and subsequent stock sale were executed according to a Rule 10b5-1 trading plan that Mr. Pande established on December 26, 2025. After completing these transactions, Mr. Pande directly holds 116,731 shares of Immunovant common stock, along with 20,000 shares held indirectly through a trust. His direct holdings of stock options, which are fully vested, currently amount to 62,181 shares, with an expiration date of November 19, 2029. For a more comprehensive understanding of IMVT's valuation and financial health, investors can review the Pro Research Report on InvestingPro.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}